Logo

Abbott Will Market Atria Genetics HLA Typing Tests

Jan 12, 2004

NEW YORK, Jan. 12 - Abbott Laboratories will distribute HLA tissue typing tests for Atria Genetics, the company said today.

 

Abbott, based in Abbott Park, Ill., obtained exclusive marketing and distribution rights for Atria's DNA sequencing-based HLA typing tests outside the US, as well as for its HLA analyte specific reagents within the US. Abbott will distribute these tests through its alliance with Celera Diagnostics.

 

Atria, based in South San Francisco, is doing business as Forensic Analytical/Molecular Genetics.

 

 

Breaking News
The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.